The President & CEO of Colfax is Exercising Options

By Carrie Williams

Yesterday it was reported that the President & CEO of Colfax (CFXResearch Report), Matthew Trerotola, exercised options to sell 200,000 CFX shares at $23.74 a share, for a total transaction value of $8.63M.

Following Matthew Trerotola’s last CFX Sell transaction on August 09, 2018, the stock climbed by 10.8%. In addition to Matthew Trerotola, one other CFX executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Colfax’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $879 million and quarterly net profit of $19.07 million. In comparison, last year the company earned revenue of $816 million and had a net profit of $4.48 million. The company has a one-year high of $50.26 and a one-year low of $24.70. Currently, Colfax has an average volume of 914.80K.

Based on 11 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $52.00, reflecting a -15.2% downside.

The insider sentiment on Colfax has been negative according to 73 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.